thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q54109361-66208A39-4D4B-4C33-8C68-2B87955470EF
Q54109361-66208A39-4D4B-4C33-8C68-2B87955470EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54109361-66208A39-4D4B-4C33-8C68-2B87955470EF
Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer: Preliminary results of a phase II study.
P2860
Q54109361-66208A39-4D4B-4C33-8C68-2B87955470EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54109361-66208A39-4D4B-4C33-8C68-2B87955470EF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ec1441b5205c3697561f874755f03b7960490cdb
P2860
Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.